Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.
about
Female with bladder cancer: what and why is there a difference?Refining patient selection for neoadjuvant chemotherapy before radical cystectomyThe safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experienceSalvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapyTailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder.Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial CarcinomaCirculating Biomarkers in Bladder Cancer.Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy.Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.Prognostic Nomogram for Advanced Hepatocellular Carcinoma Treated with FOLFOX 4Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.Tools to improve clinical trial design in urothelial cancer.Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients with Urothelial Carcinoma.Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial Carcinoma.
P2860
Q28066115-926534ED-C3B6-4CC0-8665-43AF07F4B5DAQ30408866-E7652351-8656-4F9E-8C91-2ACF2F82F933Q35586693-25458407-670F-4BD2-92AE-4C6A20D1F194Q35586740-3095D085-DEE8-4549-8021-0420189E9CEEQ35771672-C95FC815-E456-4FA2-BF6F-6A9DB8629B27Q37068034-026E180E-9727-45CD-A39C-9DEC221C1D58Q37261102-71A4A6B6-9EDB-4E4A-A90C-A163DDF6A523Q37530401-C2C52C53-032B-431C-A530-EB2DFEB17934Q38761348-CEDA12FE-FEC0-477F-8907-84D0D61E3815Q38780370-9615ABC0-57E8-4FB2-B2BF-F024ADD0048AQ38855950-B8951371-F267-4C1D-98C4-4E992E262C3CQ39303051-EF491A68-4618-4655-AE85-435547C8EC99Q41027611-2D4D1840-A2EE-4304-9758-A21A3529241CQ41381630-0ADEF9BF-8898-4227-B598-5CE443E54F9FQ41620841-977A3CA4-691E-471C-B3D0-C2F1226D9084Q46858165-1553E390-5B9A-4388-BD5F-A644AA7654BDQ47305852-0D24BB24-3109-4EBF-8D7B-F1C6C6103FE0Q47737204-0347EA12-1C0B-4693-B8C1-FB532866FDF9Q55714583-B67D49CB-4ED5-4A32-A62F-D4B2258795C8
P2860
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prognostic model for predictin ...... cisplatin-based chemotherapy.
@en
type
label
Prognostic model for predictin ...... cisplatin-based chemotherapy.
@en
prefLabel
Prognostic model for predictin ...... cisplatin-based chemotherapy.
@en
P2093
P2860
P356
P1476
Prognostic model for predictin ...... cisplatin-based chemotherapy.
@en
P2093
Alexia Iasonos
Andrea B Apolo
Dean F Bajorin
Eric J Small
George K Philips
Irina Ostrovnaya
Jamie Riches
Jonathan E Rosenberg
Matthew I Milowsky
Susan Halabi
P2860
P304
P356
10.1093/JNCI/DJT015
P407
P577
2013-02-14T00:00:00Z